Mode
Text Size
Log in / Sign up

Barriers and promoters to CGM and AID use in youth with T1D and public insuranceNew plan helps families with public insurance get life-saving diabetes tech

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that interventions effective in increasing diabetes technology uptake in youth with T1D and public insurance are necessary to mitigate disparities.

This prospective, mixed-methods study focused on youth with type 1 diabetes (T1D) who have public insurance. The investigation assessed barriers and promoters to the use of continuous glucose monitoring (CGM) and artificial insulin delivery (AID). The primary outcome measured was diabetes technology acceptance. No specific sample size, setting, or follow-up duration were reported in the available data.

The study did not report specific numerical results for technology acceptance rates, nor did it provide data on adverse events, serious adverse events, discontinuations, or general tolerability. Consequently, no specific percentages or p-values can be cited regarding the main findings or safety profile.

Key limitations include the lack of reported sample size, setting details, and follow-up duration. The study did not report funding sources or conflicts of interest. Causality was not reported, and the evidence certainty was not explicitly defined.

Practice relevance suggests that interventions effective in increasing the uptake and continued use of diabetes technology in youth with T1D and public insurance are necessary to mitigate disparities. Clinicians should recognize the need for such interventions without overstating the specific efficacy data provided by this study.

Imagine a young person living with Type 1 diabetes. They need special machines to track their sugar levels and deliver insulin automatically. These tools can save lives. Yet, many families cannot get them. This is especially true for families with public insurance.

The Hidden Gap in Care

Diabetes technology changes lives. It keeps blood sugar steady and prevents dangerous highs and lows. But there is a huge gap in who gets these tools. Families with public insurance use these devices at half the rate of more privileged groups.

This is not just about money. It is about access. Many families face barriers that stop them from getting the care they need. These barriers can be financial, cultural, or related to how doctors talk to patients. When these barriers exist, health outcomes suffer.

Why The Old Approach Fails

For years, doctors assumed that giving out free or cheap devices was enough. They thought if the cost was gone, everyone would use the tech. But this assumption misses the point. Even when devices are available, families still do not use them.

Here is the twist: the problem is not just the price tag. It is a mix of complex factors. These include fear of needles, lack of cultural trust, and confusing instructions. The old way of thinking says, "Just give them the device." The new way says, "We must understand why they hesitate first."

How The Body Handles Sugar

To understand the stakes, think of your blood sugar like a car engine. It needs a steady flow of fuel to run smoothly. If the fuel is too high or too low, the engine stalls. In the body, this stall is called a diabetic crisis.

Current technology acts like a smart autopilot. It watches the fuel levels and adjusts the flow automatically. But this autopilot only works if the driver trusts it. If a family does not trust the system, they will not turn it on. The machine sits in a box, gathering dust.

What The New Study Does

Researchers are launching a new project called BEAD-T1D. This stands for Building the Evidence to Address Disparities in Type 1 Diabetes. The team wants to find out exactly why families with public insurance struggle. They will look at every angle, from the patient's home life to the doctor's office habits.

The study uses a special method called mixed-methods. This means they will talk to people and also look at data. They want to hear the stories behind the numbers. By listening, they hope to build a better plan. The goal is to create an intervention that works for real families, not just in theory.

Finding The Real Barriers

The team will look for two main things. First, they will find what stops families from using the devices. Second, they will find what stops doctors from recommending them. Sometimes, a doctor might not suggest a device because they think the family will not use it. This creates a cycle of missed opportunities.

The study will test a pilot intervention. This is a small-scale test of a new strategy. If it works, it can be rolled out to help thousands of families. The primary goal is to increase acceptance of the technology. Acceptance means the family feels ready and willing to use the tools.

But there's a catch.

This research is not about selling a product. It is about fixing a broken system. The findings will guide future efforts to reduce disparities. Disparities mean that some people get better care than others for no reason other than their background or insurance type.

What Experts Say

Experts in the field agree that one size does not fit all. A solution that works for wealthy families might fail for families with public insurance. The new approach respects this difference. It acknowledges that culture and community play a huge role in health decisions.

By using the social-ecological model, the study looks at the whole picture. It considers the family, the school, the community, and the healthcare system. This holistic view is essential for lasting change. It moves beyond simple fixes to address deep-rooted issues.

If you know someone with Type 1 diabetes, this news is important. It means researchers are taking the struggle seriously. They are not ignoring the families who are left behind. You can expect better tools and support in the future.

However, you should talk to your doctor about your options. Ask if there are programs to help with devices. Be honest about your fears or concerns. Doctors can help you navigate the system. Together, you can find a path forward.

This study is just the beginning. It lays the groundwork for bigger changes. The team will use what they learn to build a multivariable model. This model will predict which families need the most help. It will guide the creation of new interventions.

It will take time to see results. Research takes time to move from the lab to the clinic. But the effort is worth it. Reducing disparities means every child gets a fair chance to thrive. The future of diabetes care depends on these steps. We must keep pushing for equity in healthcare.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems have led to improved outcomes in type 1 diabetes (T1D). Diabetes technology use in minoritized populations is 50% lower than more privileged groups. Tailored, multi-factorial interventions are needed to address disparities and improve technology uptake in minoritized youth with T1D. The Building the Evidence to Address Disparities in Type 1 Diabetes (BEAD-T1D) Study assesses drivers of disparities in CGM and AID use in youth with T1D and public insurance to develop an intervention to increase uptake of diabetes technology. This manuscript describes the rationale, design, and protocols of the study. BEAD-T1D is a prospective, mixed-methods study grounded in the social-ecological model informed by sequential triangulation. Study Aim 1 constructs an evidence base of barriers and promoters to CGM and AID use in youth with T1D and public insurance to formulate and test a pilot intervention to increase device uptake in minoritized populations. Study Aim 2 constructs an evidence base of barriers and promoters to recommending devices to youth with T1D and public insurance to formulate and test a pilot intervention for healthcare providers to increase recommendations of devices. The primary outcome is diabetes technology acceptance analyzed via descriptive statistics and univariate analyses to inform the systematic building of a multivariable model. BEAD-T1D lays the groundwork for future efforts to reduce disparities in the uptake and continued use of diabetes technology in marginalized populations. Interventions effective in increasing the uptake and continued use of diabetes technology in youth with T1D and public insurance are necessary to mitigate disparities.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.